OR WAIT null SECS
July 25, 2017
The agency has published a Q&A guidance document related to self-identification of facilities, review of generic drug submissions, and inspections.
July 24, 2017
Manufacturing capacity will be increased by one third and approximately 300 new high-wage and highly-skilled jobs will be created at the Fremont site.
GE Healthcare partners with Oritain for an independent test that can confirm the country of origin of fetal bovine serum (FBS), a component of biopharmaceutical production.
Industry collaboration group releases technology roadmap to address pressure on biopharmaceutical manufacturers to innovate biomanufacturing processes.
July 21, 2017
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
July 19, 2017
The advantages of single-use systems become clear as they become more broadly implemented.
ChargePoint Technology is expanding its US presence by opening a new office in San Francisco.
July 17, 2017
GSK plans to deliver up to 40 million doses of its quadrivalent flu vaccine for the 2017–2018 season.
July 12, 2017
The company has entered into a settlement agreement with generic-drug companies to resolve patent litigation.
Pfizer’s new format of ibuprofen (AdvilR Liqui-GelsR Minis) uses Catalent’s softgel technology to deliver the formulation in a more concentrated fill, resulting in smaller capsules.